Clinical Trials
3 trialsNCT03816345 2026-05-13
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT07086989 2025-08-08
CR3C
Semmelweis University
Recruiting
NCT00964210 2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3 Completed